Medical application
Title
Date Published
Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
June 29, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
April 23, 2007
Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
April 1, 2007
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.
March 6, 2007
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
March 1, 2007
Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy.
March 1, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
February 14, 2007
Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.
February 3, 2007
Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
January 23, 2007
Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure.
January 11, 2007
EPO in cancer anemia: Benefits and potential risks.
December 29, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
December 1, 2006
Correction of anemia with epoetin alfa in chronic kidney disease.
November 16, 2006
New agents that stimulate erythropoiesis.
October 10, 2006
Cardiovascular effects of erythropoietin: anemia and beyond.
July 31, 2006
Darbepoetin alfa: a review of its use in the treatment of anaemia in patients with cancer receiving chemotherapy.
June 30, 2006
Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
June 30, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
May 17, 2006
Alternatives to blood product transfusion in the critically ill: Erythropoietin.
May 1, 2006
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial*
April 4, 2006